Literature DB >> 15617753

Ventricular size mapping in a transgenic model of schizophrenia.

German Torres1, Beth A Meeder, Brian H Hallas, Joseph A Spernyak, Richard Mazurchuk, Craig Jones, Kenneth W Gross, Judith M Horowitz.   

Abstract

Genetically engineered mice have been generated to model a variety of neurological disorders. The chakragati (ckr) mouse is beginning to provide valuable insights into the structural brain changes underlying certain manifestations of schizophrenia. For instance, these mice show enlargement of the lateral ventricles, an abnormality frequently reported as a structural aberration in the schizophrenic brain. As neither the anatomical pattern nor the timing of this ventricular enlargement is known, we used magnetic resonance imaging (MRI) techniques to non-invasively visualize the development of the ventricular system in 5-, 10- and 30-day-old ckr pups. High-resolution MR images obtained from these mutants showed a progressive enlargement of the lateral ventricles, starting at day 5 of postnatal life. These emerging deficits were associated with abnormalities in mid-saggital corpus callosum area and thickness, particularly in 30-day-old adolescent animals. At this time of development, aberrant behaviors that mimic certain symptoms of schizophrenia also appeared in ckr mice suggesting that structural changes in ventricular size predates the onset of psychotic-like behaviors. These results are viewed as further indication that pre- and peri-natal disturbances of the ventricular system and adjacent neural regions may be important pathogenic factors in schizophrenia. Application of MRI to the ckr mouse is relatively new but has great potential for clarifying the relationship between brain structure changes and genetically induced vulnerabilities to psychoses.

Entities:  

Mesh:

Year:  2005        PMID: 15617753     DOI: 10.1016/j.devbrainres.2004.08.011

Source DB:  PubMed          Journal:  Brain Res Dev Brain Res        ISSN: 0165-3806


  6 in total

1.  A behavioral and molecular analysis of ketamine in zebrafish.

Authors:  Sherry M Zakhary; Diana Ayubcha; Farah Ansari; Kiran Kamran; Mehwish Karim; Joerg R Leheste; Judith M Horowitz; German Torres
Journal:  Synapse       Date:  2011-02       Impact factor: 2.562

2.  Risperidone administered during asymptomatic period of adolescence prevents the emergence of brain structural pathology and behavioral abnormalities in an animal model of schizophrenia.

Authors:  Yael Piontkewitz; Michal Arad; Ina Weiner
Journal:  Schizophr Bull       Date:  2010-05-03       Impact factor: 9.306

3.  Distribution analysis of deacetylase SIRT1 in rodent and human nervous systems.

Authors:  Sherry M Zakhary; Diana Ayubcha; Jeffery N Dileo; Riya Jose; Joerg R Leheste; Judith M Horowitz; German Torres
Journal:  Anat Rec (Hoboken)       Date:  2010-06       Impact factor: 2.064

4.  Magnetic resonance imaging and spectroscopy in a mouse model of schizophrenia.

Authors:  German Torres; Brian H Hallas; Kenneth W Gross; Joseph A Spernyak; Judith M Horowitz
Journal:  Brain Res Bull       Date:  2007-10-17       Impact factor: 4.077

5.  Altered exploration and sensorimotor gating of the chakragati mouse model of schizophrenia.

Authors:  Jared W Young; Anil Ratty; Gavin S Dawe; Mark A Geyer
Journal:  Behav Neurosci       Date:  2014-04-07       Impact factor: 1.912

6.  Prenatal immune challenge is an environmental risk factor for brain and behavior change relevant to schizophrenia: evidence from MRI in a mouse model.

Authors:  Qi Li; Charlton Cheung; Ran Wei; Edward S Hui; Joram Feldon; Urs Meyer; Sookja Chung; Siew E Chua; Pak C Sham; Ed X Wu; Grainne M McAlonan
Journal:  PLoS One       Date:  2009-07-24       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.